The University of Chicago Header Logo

Connection

Walter M. Stadler to Receptor, IGF Type 1

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Receptor, IGF Type 1.
Walter M. Stadler
Connection Strength
0.125
Receptor, IGF Type 1
  1. Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model. Ann Oncol. 2015 07; 26(7):1459-64.
    View in: PubMed
    Score: 0.125
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.